GlassScriptPhysician profile
Jean Ekwenibe
NPI 1992944433
$1,616.51
in general payments reported to CMS, 2019-2025
24 companies · $890 in 2025
The $890 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2022: $98.40 · 2023: $316 · 2024: $173 · 2025: $890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $508.58 | 2025 | Rapiblyk |
| Heartflow, INC. | $161.73 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.88 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $110.53 | 2019-2025 | Wainua |
| Pfizer INC. | $103.10 | 2023 | |
| Novartis Pharmaceuticals Corporation | $77.88 | 2019-2023 | |
| Abbott Laboratories | $65.32 | 2022-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $52.15 | 2019-2022 | |
| Amgen INC. | $43.19 | 2019-2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.70 | 2024-2025 | Lifevest |
| Solventum Corporation | $38.64 | 2024-2025 | Activ.A.C., V.A.C.Instill, Prevena |
| Baxter Healthcare | $35.88 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Merck Sharp & Dohme LLC | $32.75 | 2022-2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $32.68 | 2024 | |
| Novo Nordisk INC | $29.59 | 2019-2023 | Ozempic |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $25.41 | 2023 | Optimizer |
| Abiomed | $24.04 | 2025 | |
| Vital Connect, INC | $18.99 | 2025 | Vitalpatch Rtm |
| Vifor Pharma, INC. | $18.14 | 2019 | |
| Kestra Medical Technology Services, INC. | $16.79 | 2024 | Assure Wcd |
| Medtronic Vascular, INC. | $15.79 | 2019 | |
| Philips North America LLC | $15.71 | 2024 | (Ck4) Mcot |
| Janssen Pharmaceuticals, INC | $15.00 | 2023 | Xarelto |
| Elutia, INC. | $14.04 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Ekwenibe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.